Rhabdomyolysis in a patient receiving the combination of cerivastatin and gemfibrozil

被引：38
作者：
Bermingham, RP
Whitsitt, TB
Smart, ML
Nowak, DP
Scalley, RD
机构：
[1] Ft Collins Family Med Residency Program, Ft Collins, CO USA
[2] Heart & Vasc Clin No Colorado, Ft Collins, CO USA
[3] Yuma Clin, Yuma, CO USA
[4] Univ Wyoming, Sch Pharm, Laramie, WY 82071 USA
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2000年 / 57卷 / 05期
关键词：
D O I：
10.1093/ajhp/57.5.461
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：461 / 464
页数：4
相关论文
共 27 条
  • [1] A brief review paper of the efficacy and safety of atorvastatin in early clinical trials
    BakkerArkema, RG
    Best, J
    Fayyad, R
    Heinonen, TM
    Marais, AD
    Nawrocki, JW
    Black, DM
    [J]. ATHEROSCLEROSIS, 1997, 131 (01) : 17 - 23
  • [2] Preclinical and clinical pharmacology of cerivastatin
    Bischoff, H
    Heller, AH
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (4B) : 18J - 25J
  • [3] Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor
    Bischoff, H
    Angerbauer, R
    Bender, J
    Bischoff, E
    Faggiotto, A
    Petzinna, D
    Pfitzner, J
    Porter, MC
    Schmidt, D
    Thomas, G
    [J]. ATHEROSCLEROSIS, 1997, 135 (01) : 119 - 130
  • [4] An overview of the clinical safety profile of atorvastatin (Lipitor), a new HMG-CoA reductase inhibitor
    Black, DM
    Bakker-Arkema, RG
    Nawrocki, JW
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (06) : 577 - 584
  • [5] EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS .1. EFFICACY IN MODIFYING PLASMA-LIPOPROTEINS AND ADVERSE EVENT PROFILE IN 8245 PATIENTS WITH MODERATE HYPERCHOLESTEROLEMIA
    BRADFORD, RH
    SHEAR, CL
    CHREMOS, AN
    DUJOVNE, C
    DOWNTON, M
    FRANKLIN, FA
    GOULD, AL
    HESNEY, M
    HIGGINS, J
    HURLEY, DP
    LANGENDORFER, A
    NASH, DT
    POOL, JL
    SCHNAPER, H
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (01) : 43 - 49
  • [6] EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS .3. EFFICACY IN MODIFYING LIPOPROTEINS AND IMPLICATIONS FOR MANAGING PATIENTS WITH MODERATE HYPERCHOLESTEROLEMIA
    BRADFORD, RH
    SHEAR, CL
    CHREMOS, AN
    FRANKLIN, FA
    NASH, DT
    HURLEY, DP
    DUJOVNE, CA
    POOL, JL
    SCHNAPER, H
    HESNEY, M
    LANGENDORFER, A
    [J]. AMERICAN JOURNAL OF MEDICINE, 1991, 91 : S18 - S24
  • [7] CHICHMANIAN RM, 1991, ANN MED INTERNE, V142, P587
  • [8] Clinical efficacy and safety of cerivastatin: Summary of pivotal phase IIb/III studies
    Davignon, J
    Hanefeld, M
    Nakaya, N
    Hunninghake, DB
    Insull, W
    Ose, L
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (4B) : 32J - 39J
  • [9] Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia
    Ellen, RLB
    McPherson, R
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) : 60B - 65B
  • [10] ENDO A, 1992, J LIPID RES, V33, P1569
123